Israel Englander’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Israel Englander’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-157,000	Closed	-$1.05M	–	6719
2023 Q3	$1.05M	Buy	+157,000	New	+$1.3M	﹤0.01%	4156

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Israel Englander's PNT Position: Q4 2023 in Review

Israel Englander sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 851,735 shares — an estimated $5.68M sold.

Israel Englander first reported a position in PNT in Q4 2021 and held it in 6 quarters. The position peaked at $5.68M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Israel Englander reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Israel Englander sold 851,735 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.68M.
Israel Englander first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Israel Englander's POINT Biopharma Global Inc. Common Stock position peaked at $5.68M in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.